-
Was PSG against Bayern the Champions League's greatest ever game?
-
UBS first-quarter profits jump 80% on investment banking
-
France's 'roadmap' to exit fossil fuels by 2050
-
Chelsea captain Millie Bright retires
-
Bangladesh measles outbreak kills over 220 children since March
-
Finnish lift maker Kone acquires German rival TKE, creating giant
-
Hungary's Magyar visits Brussels seeking to unblock EU billions
-
Diving robot explores mystery of France's deepest shipwreck
-
Thai ex-PM Thaksin to be released from prison next month
-
Welsh rugby great North to hang up his boots
-
Much-needed rains revive Iraq's fabled Mesopotamian Marshes
-
French teen in straw licking case allowed to leave Singapore
-
EU chief says Kremlin imposing 'digital Iron Curtain' on Russians
-
South Korean court hikes ex-president's sentence for obstructing justice
-
Adidas reports higher profits but warns of 'volatile' climate
-
TotalEnergies first-quarter profits surge amid Middle East war
-
Sri Lanka government 'temporarily' takes over cricket board
-
EU finds Meta failing to keep under-13s off Facebook, Instagram
-
King Charles to stress UK-US cultural, trade ties in New York
-
US judge orders Purdue Pharma to pay billions ahead of bankruptcy
-
'Jurassic Park' star Sam Neill says cancer-free after gene therapy
-
US opioid crisis victims testify at emotional Purdue Pharma hearing
-
Australian climber on record sea-to-summit Everest bid
-
Indian opposition slams Nicobar megaport plan as 'destruction'
-
Pentagon chief to testify on Iran war, peace efforts stall
-
Anxiety, resentment around AI spur violence against tech's figureheads
-
Mercedes-Benz profit slides amid cutthroat Chinese market
-
Hungary's Magyar to push post-Orban EU reset on Brussels visit
-
Going online helps Pakistan's women doctors back to work
-
Wembanyama's Spurs advance in NBA playoffs, 76ers stay alive
-
Tropical forest loss eases after record year: researchers
-
Tigres edges Nashville in CONCACAF Champions Cup first leg
-
New Zealand officials reject statue remembering Japan's sex slaves
-
King Charles, Trump toast ties despite Iran tensions
-
Japan cleaner goes viral with spa-like service for plushies
-
What we learned from cycling's Spring Classics
-
Villa, Forest revive European glory days in semi-final showdown
-
Remarkable, ramshackle Rayo chasing Conference League dream amid chaos
-
Unbeaten records on the line for Inoue-Nakatani superfight in Tokyo
-
Cheaper, cleaner electric trucks overhaul China's logistics
-
Stocks swing, oil edges up with Iran war peace talks stalled
-
Europe climate report signals rising extremes
-
Sexual violence in Sudan triggers mental health crisis: UN
-
The loyal, lonely keepers of Sudan's pyramids
-
'Final mission': NZ name star trio for T20 World Cup defence
-
Embiid-led 76ers beat Boston to avoid NBA playoff exit
-
An experimental cafe run by AI opens in Stockholm
-
Exiting fossil fuels key to energy security: nations at Colombia talks
-
Jerome Powell: Fed chair who stood up to Trump set to finish tenure on top
-
All eyes on Powell with US Fed expected to hold rates steady
Musk's Neuralink eyes more test subjects for its brain tech
Elon Musk on Wednesday said his Neuralink startup is "moving on" to a second test patient as its tech for linking brains and computers improves.
Musk and members of the Neuralink team fielded questions during an update streamed on X, formerly Twitter, discussing where it is on the path to making its brain implants commonplace.
"We're only just moving now to our second Neuralink patient," Musk said. "But we hope to have, if things go well, high single digits this year."
Musk's neurotechnology company in January installed a brain implant in Noland Arbaugh, which the billionaire head of Tesla and X touted as a success.
Arbaugh was left paralyzed from the shoulders down by a diving accident eight years ago.
Since the implant operation, he has told of playing chess and the video game "Civilization," as well as taking Japanese and French lessons by controlling a computer screen cursor with his brain.
Musk and members of the Neuralink team detailed fixing an issue that saw Arbaugh's ability to move a computer cursor with his mind greatly reduced.
Neuralink's technology works through a device about the size of five stacked coins that is placed inside the human brain by a robotic surgeon.
Threads connecting the implant to Arbaugh's brain had "retracted," becoming less effective at picking up signals.
Threads will be implanted deeper in the brain and at varying depths, with ramped-up precision to maximize effectiveness, according to the Neuralink team.
Musk promised "it's only going to get better from here."
One goal is to escalate the bandwidth of the link between the brain and computer, allowing more data to move faster, according to Musk.
"Quite important for human-AI symbiosis is just being able to communicate at a speed AI can follow," Musk said of brains being connected to computers with artificial intelligence.
Musk envisions Neuralink implants going beyond restoring sight to the blind to giving people infrared or ultraviolet vision or letting them share concepts with others telepathically.
"We want to give people superpowers," Musk said. "Not just that we're restoring your prior functionality, but that you actually have functionality far greater than a normal human."
Musk spoke of developing an automated process in which Neuralink's surgery robot could quickly install custom implants in people seeking "upgrades."
"It's very sort of 'Cyberpunk' or 'Deus Ex,' if you play those games," Musk said of the idea.
"An exciting possibility long term also is to take parts of the Optimus humanoid robot and combine that with a Neuralink - you could have basically cybernetic superpowers," he said.
Musk cofounded Neuralink in 2016.
The ambition is to supercharge human capabilities, treat neurological disorders like ALS or Parkinson's, and maybe one day achieve a symbiotic relationship between humans and AI.
Musk is not alone in trying to make advances in the field, which is officially known as brain-machine or brain-computer interface research.
T.Ward--AMWN